Chemical radiation sensitizers and protectors: recent developments.
D004999:Amifostine / Q000494:pharmacology; D003543:Cysteamine / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000494:pharmacology; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010100:Oxygen / Q000494:pharmacology; D011837:Radiation-Protective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D004273:DNA, Neoplasm; D009593:Nitroimidazoles; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D013438:Sulfhydryl Compounds; D003543:Cysteamine; D003545:Cysteine; D004999:Amifostine; D010100:Oxygen